By Jeff Montgomery (June 8, 2022, 7:45 p.m. EDT) — Bankrupt drugmaker Mallinckrodt PLC announced Wednesday that its Chapter 11 plan will most likely go into effect on June 14, following eleventh-hour approval of a $650 million exit financing that replaced – at a much higher cost – a $900 million exit financing deal.
Michael J. Merchant of Richards Layton & Finger PA, debtors’ attorney, told U.S. Bankruptcy Judge John T. Dorsey that “we think we’re about to go into effect on Tuesday,” with the new, smaller and more expensive $650 million in noteholder financings are expected to be locked in on Monday.
The revised term loan plan, not publicly discussed…
Stay one step ahead
In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.
Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and more!